Daniel C Julien Kara Woolgar Laura Pollard Holly Miller Ankit Desai Kristin Lindstrom Priya S Kishnani
10.3389/fimmu.2020.01000
Front Immunol
2020 May 21;11:1000.
mps ii enzyme replacement therapy hunter syndrome immune modulation neutralizing antibodies
CC BY
https://pubmed.ncbi.nlm.nih.gov/32508845/
Enzyme Replacement Therapy / methods Iduronate Sulfatase / therapeutic use Immunoglobulins, Intravenous / therapeutic use Mucopolysaccharidosis II / therapy Rituximab / therapeutic use
Enzyme Replacement Therapy / methods Iduronate Sulfatase / therapeutic use Immunoglobulins, Intravenous / therapeutic use Mucopolysaccharidosis II / therapy Rituximab / therapeutic use Case Reports Antibodies, Neutralizing / metabolism Child, Preschool Female Humans Iduronate Sulfatase / genetics Iduronate Sulfatase / immunology Immune Tolerance Mucopolysaccharidosis II / immunology Sequence Deletion Antibodies, Neutralizing Immunoglobulins, Intravenous Rituximab Iduronate Sulfatase
PMC7253587
32508845
Immune Modulation for Enzyme Replacement Therapy in A Female Patient With Hunter Syndrome
2020